Atlas Trials

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Clinical trial NCT06800313 · RECRUITING

Trial details

NCT number
NCT06800313
Sponsor
Janssen Research & Development, LLC
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Prostate Cancer
Start date
2025-02-06
Primary completion
2028-07-11
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.